PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jnutrPublished VersionSearchSubmit ManuscriptSubscribeAll Articles
 
J Nutr. 2013 May; 143(5): 606–612.
Published online 2013 March 6. doi:  10.3945/jn.112.171520
PMCID: PMC3738233

Genetic Variants Influencing Biomarkers of Nutrition Are Not Associated with Cognitive Capability in Middle-Aged and Older Adults1,2,3

Abstract

Several investigations have observed positive associations between good nutritional status, as indicated by micronutrients, and cognitive measures; however, these associations may not be causal. Genetic polymorphisms that affect nutritional biomarkers may be useful for providing evidence for associations between micronutrients and cognitive measures. As part of the Healthy Ageing across the Life Course (HALCyon) program, men and women aged between 44 and 90 y from 6 UK cohorts were genotyped for polymorphisms associated with circulating concentrations of iron [rs4820268 transmembrane protease, serine 6 (TMPRSS6) and rs1800562 hemochromatosis (HFE)], vitamin B-12 [(rs492602 fucosyltransferase 2 (FUT2)], vitamin D ([rs2282679 group-specific component (GC)] and β-carotene ([rs6564851 beta-carotene 15,15'-monooxygenase 1 (BCMO1)]. Meta-analysis was used to pool within-study effects of the associations between these polymorphisms and the following measures of cognitive capability: word recall, phonemic fluency, semantic fluency, and search speed. Among the several statistical tests conducted, we found little evidence for associations. We found the minor allele of rs1800562 was associated with poorer word recall scores [pooled β on Z-score for carriers vs. noncarriers: −0.05 (95% CI: −0.09, −0.004); P = 0.03, n = 14,105] and poorer word recall scores for the vitamin D–raising allele of rs2282679 [pooled β per T allele: −0.03 (95% CI: −0.05, −0.003); P = 0.03, n = 16,527]. However, there was no evidence for other associations. Our findings provide little evidence to support associations between these genotypes and cognitive capability in older adults. Further investigations are required to elucidate whether the previous positive associations from observational studies between circulating measures of these micronutrients and cognitive performance are due to confounding and reverse causality.

Introduction

Adequate nutrition is essential for good health throughout the life course, and low-quality diets in later life have been associated with adverse outcomes, such as increased risk of coronary heart disease (1) and mortality (2, 3). Measures of dietary intake of specific micronutrients, along with their biomarkers, have also been associated with indicators of health in observational epidemiologic studies and there is evidence from many, although not all, studies that micronutrients are important to cognitive outcomes (4, 5). Iron deficiency anemia is negatively associated with cognitive performance in childhood (6), and positive associations between cognitive measures and several other micronutrients have also been observed in adults including circulating concentrations of vitamin B-12 (7) and vitamin D (8, 9) and intake (10) and plasma concentrations of β-carotene (11).

The associations observed between nutrition and cognitive measures may not, however, be causal in all cases. Animal studies have shown that a diet rich in antioxidants may delay cognitive aging (12), studies in children with iron deficiency anemia show iron supplementation may improve cognition (6), and there is evidence for improvements in cognition from some, although not all, intervention studies for nutrients in adults (13). Whereas mixed evidence from intervention studies may be partly due to inadequately short treatment lengths for the observation of effects on cognitive measures, there are other possible noncausal explanations for the associations observed between nutrients and cognitive measures. For example, effects may be due to the lifestyle factors that have been associated with the intake of some nutrients (14) or due to cognitive impairment leading to reduced nutrient intake (4). Genetic variants associated with biomarkers of nutrition may be useful in providing evidence for associations with cognitive measures. Any associations would be less likely to be due to confounding (15) or reverse causality (16). The assumptions for this hypothesis are presented in Supplemental Fig. 1. Furthermore, genetic variants implicated in the circulating concentrations of biomarkers of nutrition may be additionally informative about the long-term effects of lower concentrations.

We therefore investigated the associations between genetic variants implicated in the concentrations of biomarkers of nutrition, from genome-wide association studies (GWASs)15, and measures of cognitive capability, the capacity to undertake the mental tasks of daily living, in 20,528 participants aged between 44 and 90 y as part of the Healthy Ageing across the Life Course (HALCyon) (17) collaborative research program. Although micronutrient biomarkers may not be direct measures of dietary intake in generally well-nourished individuals, they are important indicators of deficiency and storage.

Serum iron is ~23% heritable (18), and increased concentrations have been associated with the A allele of the single nucleotide polymorphism (SNP) rs4820268 in transmembrane protease, serine 6 (TMPRSS6) (19, 20) and with the A allele of rs1800562 (C282Y) in hemochromatosis (HFE) (21), the former being common in many populations, whereas homozygosity of the latter is present in <0.5% of individuals of European ancestry (22) and is found in 80% of individuals with hemochromatosis (23), an iron overload syndrome. The G allele of rs492602 in fucosyltransferase 2 (FUT2) has been associated with increased plasma vitamin B-12 (24). SNPs that contribute to the estimated 28% heritability of concentrations of 25-hydroxyvitamin D in individuals of European ancestry (25) have also been identified, with the T allele of rs2282679 [group-specific component (GC)] associated with higher concentrations (26, 27). The G allele of SNP rs6564851 near beta-carotene 15,15'-monooxygenase 1 (BCMO1) has been associated with higher β-carotene, an antioxidant precursor to vitamin A (28). We hypothesized that these variants, identified from GWASs, would be associated with measures of cognitive capability, such as verbal memory and fluency, in our studies in middle-aged and older adults.

Materials and Methods

Study populations

The National Child Development Study (NCDS) has followed up all individuals born in England, Scotland, and Wales during 1 wk in March 1958. In 2002–2004 a biomedical survey was conducted during home visits by a research nurse. After informed consent, DNA was extracted from 8017 participants aged 44–45 y; the sample with the immortalized cell line culture (n = 7526) is used here. In 2008–2009, an eighth sweep was carried out during which cognitive performance tests were conducted (29). Further details of the study are available elsewhere (30). The Medical Research Council National Survey of Health and Development (NSHD) comprises participants sampled from all births in a week in March 1946 and followed up since then. In 1999, at age 53 y, men and women were visited by a research nurse and consent for DNA extraction was given by ~2900 members of the cohort. Details of the data collected and the several phases of the study are available on the cohort’s website (31) and elsewhere (32).

The Whitehall II study targeted all civil servants aged between 35 and 55y working in London in 1985–1988. In 2002–2004 (phase VII), the genetics study was established and DNA was extracted from 6156 participants. Details of the study design and data collected have been described elsewhere (33).

The Caerphilly Prospective Study (CaPS) recruited 2512 men aged between 45 and 59 y in 1979–1983 from the town of Caerphilly, South Wales, and its surrounding villages. Blood samples were collected at baseline and at each of the 4 follow-ups (phase II: 1984–1988; phase III: 1989–1993; phase IV: 1993–1997; and phase V: 2002–2004.) Further details are available on the cohort’s website (34).

The English Longitudinal Study of Ageing (ELSA) comprises men and women aged ≥50 y who originally participated in the Health Survey for England in 1998, 1999, or 2001. Fieldwork began in 2002–2003 (phase I) with biennial follow-ups, and in 2004–2005 (phase II) blood samples were provided by 6231 participants. Details of the cohort have been published elsewhere (35).

The Lothian Birth Cohort 1921 (LBC1921) participants were all born in 1921, and most completed a cognitive ability assessment at age 11 y. In 1999–2001 (wave I), at age ~79 y, 550 participants living in and around Edinburgh underwent a series of cognitive and physical tests. Details of the recruitment into the study are available on its website (36) and have been published previously (37, 38).

Informed consent was obtained from all participants. Ethical approval was obtained from the South-east Multi-center Research Ethics Committee, the North Thames Multi-center Research Ethics Committee, the Joint University College London/University College London Hospitals Committees on the Ethics of Human Research (Committee Alpha), the Medical Research and Ethics Committee, and the Lothian Research Ethics Committee.

Genotyping and quality control

Genotyping for all SNPs [rs4820268 (TMPRSS6, 22q12.3), rs1800562 (C282Y, HFE, 6p22.2), rs492602 (FUT2, 19q13.33), rs2282679 (GC, 4q13.3), and rs6564851 (near BCMO1, 16q23.2)] in CaPS and ELSA were carried out by KBioscience (39) along with rs492602 in NCDS and rs2282679 in NSHD. Genotype information for the remaining SNPs in NSHD and all SNPs in Whitehall II came from the Illumina Metabochip (40). Genotype information for all SNPs in LBC1921 came from the Illumina Human 610-Quadv1 Chip (41), with rs492602 imputed by using the HapMap phase II CEU data [National Center for Biotechnology Information build 36 (UCSC hg18)] as the reference sample and MACH software; imputation quality score was high (r2 = 0.99). The remaining SNPs in NCDS came from 2 sources: Illumina HumanHap 550k v3 and Illumina 1.2M chips (42). Genotypic data quality was reviewed by assessing departure from the Hardy-Weinberg equilibrium, clustering quality (using KBioscience software SNPviewer on their data) and call rates.

Phenotypes

Cognitive capability.

A number of cognitive performance tests in the different studies were used to assess cognitive capability. Different assessments of verbal memory were conducted: in ELSA and NCDS, a list of 10 common words were used with participants asked to recall the list immediately and again after a delay (the mean score was used in the analysis); in NSHD, 15 words were used over 3 trials; in Whitehall II, 20 words were used. Responses in NSHD and Whitehall II were given in writing. In Whitehall II, participants recalled in writing in 1 min as many words as possible beginning with “S” to assess phonemic fluency, whereas in LBC1921 the 3 letters “C,” “F,” and “L” were used with responses given orally. Participants were asked to recall as many animals as possible within 1 min to measure semantic fluency; responses were given orally in ELSA, NCDS, CaPS, and NSHD and in writing in Whitehall II. To assess search speed (43), 1-min letter searches among grids of letters were used: 600 letters in NSHD and 780 in ELSA and NCDS.

Anthropometric measurements.

BMI (kg/m2) was calculated as weight divided by height squared derived from measurements conducted at clinics, during a clinical interview in the home, or from self-report. Waist-hip ratio was defined as waist circumference (cm) divided by hip circumference (cm).

Demographic characteristics.

Demographic information was derived from self-report. Where information on ethnicity was collected, participants of non-European ancestry were excluded from analyses to avoid confounding from population stratification (44). Levels of physical activity were derived from questionnaires. Individuals were categorized as “physically active” in this analysis if they engaged, at least once a month, in at least moderate sport or activities in NCDS, NSHD, CaPS, and LBC1921 or in vigorous sport or activities in ELSA and Whitehall II. Participants’ alcohol consumption was dichotomized here into “at least weekly” and “less often” in all studies, except for NSHD, where “more often than special occasions” and “less often” were used. Data on current smoking status and socioeconomic position were also used.

Statistical methods

Within studies, linear and logistic regression analyses were conducted on the continuous and dichotomous traits within the cohorts respectively, adjusting for sex in all studies except for CaPS and for age in all studies except for those that were age homogenous (i.e., NCDS, NSHD, and LBC1921). Adjustments for anthropometric measures in the cognitive capability models were made where appropriate. NCDS and NSHD were used to additionally adjust the genotypic effects of rs4820268 for glycated hemoglobin (Hb A1c), and of rs1800562 for Hb A1c and LDL cholesterol in the cognitive capability models, due to evidence for associations with these traits (45, 46). Dominant models were used for rs1800562 due to the low frequency of individuals homozygous for the minor alleles (n = 92; 0.6%). Additive models for the other SNPs were used with genotypes coded as 0, 1, and 2 for the number of biomarker-raising alleles. Likelihood ratio tests were used to compare the fit of the additive models compared with the full genotype model for the cognitive capability traits. For continuous traits, the normality of the standardized residuals was inspected with distributional diagnostic plots. For the harmonization of continuous traits that were used to obtain pooled estimates of the genotypic effects, Z-score units were calculated in each study by subtracting the study mean and dividing by its SD. The overall mean for Z-scores is 0 and the SD is 1. Two-step (47) meta-analyses using a random-effects model were performed to obtain pooled genotypic effects. The I2 measure was used to quantify heterogeneity (48). Finally, the calculation of Z-scores, for continuous traits, and the main analyses were repeated in men and women separately. Reporting of the analyses met the appropriate items of recommended checklists (49, 50). A 2-tailed significance level of P < 0.05 was used as evidence of statistical significance. Statistical analysis was performed in Stata 11.2 (StataCorp LP).

Results

Cohort summaries and genotyping quality.

Table 1 shows that a total of 20,528 men and women aged between 44 and 90 y had relevant genotypic and phenotypic data. Summary measures of the anthropometric and demographic variables in the cohorts are presented in Supplemental Table 1. Call rates were high, exceeding 94% for all SNPs across the studies. The Hardy-Weinberg equilibrium condition was met for all SNPs in both sources of NCDS and in all other studies (P > 0.06).

TABLE 1
Summary of sex, age, and nutrient biomarker–raising allele frequencies by cohort1

Associations between genotype and phenotypes.

Associations between the genotypes and measures of anthropometry and demographic factors are presented in Supplemental Tables 2–4. There was some evidence that the A allele of rs4820268 (TMPRSS6) was associated with lower weight (P = 0.02) and BMI (P = 0.01) (Supplemental Table 2). There was no evidence for other genotypic associations for the anthropometric measures or for physical activity, smoking status, alcohol consumption, or socioeconomic position (P > 0.07).

Summaries of the pooled genotypic associations with the cognitive capability measures are presented in Table 2. A negative association between the A allele of rs4820268 (TMPRSS6) and phonemic fluency was observed in LBC1921, but not in Whitehall II, resulting in substantial heterogeneity (I2 = 83.1%, P = 0.02; Supplemental Fig. 2, Supplemental Table 5), and there was no overall effect, after adjusting for age, sex, height, and weight. There was some evidence that carriers of the A allele of rs1800562 (HFE) had lower word recall scores after adjusting for age and sex (P = 0.03), as well as for a trend toward slower search speeds (P = 0.08; Supplemental Fig. 3, Supplemental Table 6). We also observed trends toward associations between the G allele of rs492602 (FUT2) and poorer performance in semantic fluency (P = 0.06) and search speed (P = 0.05) (Supplemental Table 7 and Supplemental Fig. 4). Table 2 shows that there was some evidence that the T allele of rs2282679 (GC) was associated with lower word recall scores after adjusting for age and sex (P = 0.03), although no other pooled associations were observed for this SNP. Differences were observed for the genotypic effects of rs2282679 (GC) on phonemic fluency between LBC1921 and Whitehall II (I2 = 80.6%, P = 0.02), with a negative effect of the T allele observed only in LBC12921 (Supplemental Fig. 5, Supplemental Table 8). A positive association between the G allele of rs6564851 (BCMO1) and word recall was observed only in NSHD, with no overall effect from all 4 studies (heterogeneity: I2 = 70.5%, P = 0.02; Table 2, Supplemental Table 9, and Supplemental Fig. 6).

TABLE 2
Summary of pooled associations between genotypes and cognitive capability1

There was no evidence for other genotypic associations for the measures of cognitive capability in the pooled analyses. In only a relatively small number of tests did the full genotype model represent a significantly better fit than the per allele model (indicated in Supplemental Tables 7 and 8). Full genotypic associations are presented in Supplemental Tables 5–9 and Supplemental Figs. 2–6. There was no evidence for heterogeneity between men and women for any of the genotypic associations for any of the cognitive capability measures (P > 0.08; data not shown), except for rs6564851 (BCMO1) where its effects on search speed differed (P-heterogeneity = 0.045), although not achieving significance in either sex (men, P = 0.05; women, P = 0.41).

Additional adjustment for Hb A1c in the models of effects of rs4820268 (TMPRSS6) in NCDS and NSHD did not affect the null associations observed in those studies, nor did the adjustment for LDL cholesterol and Hb A1c for rs1800562 (HFE) attenuate the pooled negative association between the A allele and word recall for the 2 studies [(n = 7042; pooled β for Z-score: −0.09 (95% CI: −0.16, −0.03); P = 0.005, I2 = 0.0%)], nor markedly affect any of the other associations (data not shown).

Discussion

We investigated associations between SNPs robustly associated with nutritional biomarkers from GWASs and measures of cognitive capability in 20,528 adults aged between 44 and 90 y from 6 UK cohorts. There was little evidence for important associations, with some evidence that carriers of the serum-raising and hemochromatosis-predisposing allele of rs1800562 (C282Y) in HFE performed poorer in word recall tests (P = 0.03). We also observed a negative association between the allele of rs2282679 (GC) associated with higher vitamin D and word recall (P = 0.03), as well as a trend toward poorer performance in semantic fluency and search speed for the allele of rs492602 (FUT2), which is associated with higher vitamin B-12 (24). We observed no associations between SNP rs4820268 (TMPRSS6), associated with relatively lower effects on serum iron than C282Y (51), or between the SNP associated with β-carotene, rs6564851 (BCMO1), on any of our investigated cognitive capability traits. Our findings therefore suggest that the genotypes that affect these nutritional biomarkers have little, if any, association with measures of cognitive capability, including verbal fluency and memory in middle-aged and older adults.

Given the burden of cognitive decline in aging populations (5), inferring causality between biomarkers of nutrition and cognitive measures could have implications for public health policy, and there have been several investigations into associations between dietary intake, or circulating measures, of micronutrients on cognitive measures, with some positive associations observed (4). However, these associations may be confounded by lifestyle factors, be due to better cognition informing better nutritional choices (4), or reflect temporary nutritional status only. There have been fewer investigations using genetic markers implicated in the circulating concentrations, which may help to reduce these effects of confounding and reverse causality and help to investigate the effects of long-term levels of exposure (15, 16). One smaller study in 818 men and women aged between 50 and 70 y observed no association between C282Y (HFE) and several cognitive measures (52), and a study in 358 men observed no association between genotypes of HFE and performance in the Mini-Mental State Examination, but there was some evidence that the genotypes did modify the effects of lead burden on the change in scores (53). With the emergence of robust genotypic associations identified from GWASs, we were able to investigate the effects of circulating concentrations of serum iron as well as additional markers on cognitive capability. The overall null associations we found between the investigated genotypes associated with nutritional biomarkers and cognitive capability do not support a hypothesis of direct causal effects.

There are, however, various hypothesized mechanisms through which micronutrients may directly affect cognitive capability. Animal studies have shown that iron deficiency leads to an increase in iron uptake in the brain (54), and increased iron content is often seen in the brains of patients with neurodegenerative diseases, including Alzheimer disease (55) and Parkinson disease (56), and it has been suggested that iron deficiency may be implicated in such diseases (57), although its role is not fully understood. Low B vitamin status may also affect brain tissue by impairing necessary homocysteine methylation (58). In addition, higher concentrations of plasma vitamin B-12 have been associated with lower rates of brain volume loss in the elderly (59). The brain’s susceptibility to free radical damage makes antioxidants important actors in its defense from oxidative stress (60) and as a result may also affect cognitive capability.

It is therefore possible that these micronutrients may be able to affect cognitive capability measures, and despite the large size of our study it may still have been underpowered to provide strong evidence for these effects. In addition to this, there are other factors to be considered in the interpretation of results from our investigation. Interpretation of a few of our findings may be hindered by large heterogeneity that we observed and further investigations may explain any possible sources. The inverse association observed between the vitamin D–raising allele and word recall from the pooled results was not seen for any of the other cognitive measures and may therefore be spurious, especially in light of the number of statistical tests conducted. It is possible that the association we observed between the serum iron–raising allele of rs1800562 (C282Y) in HFE and poorer word recall is an indicator of any effect of a predisposition to hemochromatosis, a syndrome often accompanied by fatigue and malaise (23), and not directly of serum iron, because this association was not observed for the rs4820268 (TMPRSS6) genotype. Residual confounding may be reduced further by the inclusion of several genotypes for each micronutrient (61), possibly providing stronger instruments for investigating causality (16).

Although our study found no strong evidence for associations between these genotypes and cognitive capability, attention should still be given to improving and maintaining the overall quality of diets of older people in order to reduce the risk of morbidity and mortality associated with poor diets (13). In addition, there is still a possible role of macronutrients in cognitive performance (4). Maintenance of good nutritional status in older adults is particularly important due to physiologic factors and reduced dietary intake of nutrients that may occur in later life, which contribute to the lower concentrations of nutritional biomarkers observed in older age (4, 62). However, food sources may be preferable to pharmacologic supplements because supplementation of synthetic antioxidants, such as β-carotene, and minerals, such as iron, in generally well-nourished individuals may lead to adverse outcomes, such as increased mortality risk (63, 64).

In conclusion, the results of this large multicohort study using genetic variants of nutritional biomarkers require replication but provide little evidence for associations with cognitive capability in middle-aged and older adults.

Supplementary Material

Online Supporting Material:

Acknowledgments

The authors thank Jorgen Engmann, Jon Johnson, Aida Sanchez, Andrew Taylor, and Andrew Wong for providing data. They also thank the Scottish Council for Research in Education for allowing access to the Scottish Mental Survey 1932. The HALCyon study team also includes: Catharine Gale, James Goodwin, Alison Lennox, Marcus Richards, Thomas von Zglinicki, John Gallacher, Gita Mishra, Paul Shiels, Humphrey Southall, Andrew Steptoe, Panos Demakakos, Kate Tilling, Lawrence Whalley, Geraldine McNeill, Leone Craig, Carmen Martin-Ruiz, Paula Aucott, Emily Murray, Zeinab Mulla, Mike Gardner, and Sam Parsons. I.N.M.D. conceived and designed the experiments; T.A. analyzed the data and drafted the manuscript: I.N.M.D. and Y.B.-S. advised on the statistical analyses and contributed to the manuscript; D.K. contributed the HALCyon program; Y.B.-S., I.J.D., J.E., M. Kumari, C.P., and D.K. contributed studies to the project; and R.C., R.H., I.J.D., J.E., S.E.H., E.H., M. Kivimaki, M. Kumari, J.M., C.P., J.M.S., and D.K. provided comments on the manuscript. All authors read and approved the final version of the manuscript.

Footnotes

15Abbreviations used: BCMO1, beta-carotene 15,15'-monooxygenase; CaPS, Caerphilly Prospective Study; ELSA, English Longitudinal Study of Ageing; FUT2, fucosyltransferase 2; GC, group-specific component; GWAS, genome-wide association study; HALCyon, Healthy Ageing across the Life Course; Hb A1c, glycated hemoglobin; HFE, hemochromatosis; LBC1921, Lothian Birth Cohort 1921; NCDS, National Child Development Study; NHSD, National Survey of Health and Development; SNP, single nucleotide polymorphism; TMPRSS6, transmembrane protease, serine 6.

Literature Cited

1. Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72:912–21. [PubMed]
2. Haveman-Nies A, de Groot LPGM, Burema J, Cruz JAA, Osler M, van Staveren WA. Dietary quality and lifestyle factors in relation to 10-year mortality in older Europeans: the SENECA study. Am J Epidemiol. 2002;156:962–8. [PubMed]
3. Huijbregts P, Feskens E, Räsänen L, Fidanza F, Nissinen A, Menotti A, Kromhout D. Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and The Netherlands: longitudinal cohort study. BMJ. 1997;315:13–7. [PMC free article] [PubMed]
4. Del Parigi A, Panza F, Capurso C, Solfrizzi V. Nutritional factors, cognitive decline, and dementia. Brain Res Bull. 2006;69:1–19. [PubMed]
5. Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, Penke L, Rafnsson SB, Starr JM. Age-associated cognitive decline. Br Med Bull. 2009;92:135–52. [PubMed]
6. Hermoso M, Vucic V, Vollhardt C, Arsic A, Roman-Viñas B, Iglesia-Altaba I, Gurinovic M, Koletzko B. The effect of iron on cognitive development and function in infants, children and adolescents: a systematic review. Ann Nutr Metab. 2011;59:154–65. [PubMed]
7. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr. 2002;75:908–13. [PubMed]
8. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170:1135–41. [PubMed]
9. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci. 2011;66:59–65. [PMC free article] [PubMed]
10. Jama JW, Launer LJ, Witteman JC, den Breeijen JH, Breteler MM, Grobbee DE, Hofman A. Dietary antioxidants and cognitive function in a population-based sample of older persons: the Rotterdam Study. Am J Epidemiol. 1996;144:275–80. [PubMed]
11. Perrig WJ, Perrig P, Stähelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc. 1997;45:718–24. [PubMed]
12. Joseph JA, Shukitt-Hale B, Denisova NA, Prior RL, Cao G, Martin A, Taglialatela G, Bickford PC. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci. 1998;18:8047–55. [PubMed]
13. Bandayrel K, Wong S. Systematic literature review of randomized control trials assessing the effectiveness of nutrition interventions in community-dwelling older adults. J Nutr Educ Behav. 2011;43:251–62. [PubMed]
14. Jenab M, Salvini S, van Gils CH, Brustad M, Shakya-Shrestha S, Buijsse B, Verhagen H, Touvier M, Biessy C, et al. Dietary intakes of retinol, beta-carotene, vitamin D and vitamin E in the European Prospective Investigation into Cancer and Nutrition cohort. Eur J Clin Nutr. 2009;63(Suppl 4):S150–78. [PubMed]
15. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 2007;4:e352. [PMC free article] [PubMed]
16. Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008;5:e177. [PMC free article] [PubMed]
17. Halcyon.ac.uk [Homepage on the Internet]. HALCyon project [cited 2012 Dec 5]. Available from: http://www.halcyon.ac.uk/
18. Njajou OT, Alizadeh BZ, Aulchenko Y, Zillikens MC, Pols HAP, Oostra BA, Swinkels DW, van Duijn CM. Heritability of serum iron, ferritin and transferrin saturation in a genetically isolated population, the Erasmus Rucphen Family (ERF) Study. Hum Hered. 2006;61:222–8. [PubMed]
19. Tanaka T, Roy CN, Yao W, Matteini A, Semba RD, Arking D, Walston JD, Fried LP, Singleton A, et al. A genome-wide association analysis of serum iron concentrations. Blood. 2010;115:94–6. [PubMed]
20. Pichler I, Minelli C, Sanna S, Tanaka T, Schwienbacher C, Naitza S, Porcu E, Pattaro C, Busonero F, et al. Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet. 2011;20:1232–40. [PMC free article] [PubMed]
21. Benyamin B, Ferreira MAR, Willemsen G, Gordon S, Middelberg RPS, McEvoy BP, Hottenga J-J, Henders AK, Campbell MJ, et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet. 2009;41:1173–5. [PMC free article] [PubMed]
22. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–78. [PubMed]
23. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139:393–408, 408.e1–2. [PubMed]
24. Hazra A, Kraft P, Selhub J, Giovannucci EL, Thomas G, Hoover RN, Chanock SJ, Hunter DJ. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet. 2008;40:1160–2. [PMC free article] [PubMed]
25. Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, D’Agostino RB, Sr, Ordovas JM, O’Donnell CJ, Dawson-Hughes B, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2009;63:458–64. [PMC free article] [PubMed]
26. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180–8. [PMC free article] [PubMed]
27. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19:2739–45. [PMC free article] [PubMed]
28. Ferrucci L, Perry JRB, Matteini A, Perola M, Tanaka T, Silander K, Rice N, Melzer D, Murray A, et al. Common variation in the beta-carotene 15,15’-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet. 2009;84:123–33. [PubMed]
29. Brown M, Dodgeon B. NCDS cognitive assessments at age 50: initial results. London: Centre for Longitudinal Studies. Working Paper 2010/1;2010.
30. Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol. 2006;35:34–41. [PubMed]
31. MRC National Survey for Health and Development [Homepage on the Internet] [cited 2012 Dec 5]. Available from: http://www.nshd.mrc.ac.uk/
32. Wadsworth M, Kuh D, Richards M, Hardy R. Cohort profile: the 1946 National Birth Cohort (MRC National Survey of Health and Development). Int J Epidemiol. 2006;35:49–54. [PubMed]
33. Marmot M, Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol. 2005;34:251–6. [PubMed]
34. Bristol University, School of Social and Community Medicine. Caerphilly Prospective Study [cited 2012 Dec 5]. Available from: http://www.bris.ac.uk/social-community-medicine/projects/caerphilly/
35. Marmot M, Banks J, Blundell R, Lessof C, Nazroo J., editors. Health, wealth and lifestyles of the older population in England: the 2002 English Longitudinal Study of Aging. London: Institute for Fiscal Studies;2003.
36. The Lothian birth cohorts of 1921 and 1936 [cited 2012 Dec 5]. Available from: http://www.lothianbirthcohort.ed.ac.uk/
37. Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC. The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol. 2004;86:130–47. [PubMed]
38. Deary IJ, Gow AJ, Pattie A, Starr JM. Cohort profile: the Lothian birth cohorts of 1921 and 1936. Int J Epidemiol. 2012;41(6):1576–84. [PubMed]
39. LGC Genomics, KBioscience [Homepage on the Internet] [cited 2012 Dec 5]. Available from: http://www.lgcgenomics.com/
40. Illumina, Inc. [Homepage on the Internet] [cited 2012 Dec 5] Available from: http://www.illumina.com/
41. Houlihan LM, Davies G, Tenesa A, Harris SE, Luciano M, Gow AJ, McGhee KA, Liewald DC, Porteous DJ, Starr JM. Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time. Am J Hum Genet. 2010;86:626–31. [PubMed]
42. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–78. [PMC free article] [PubMed]
43. Richards M, Kuh D, Hardy R, Wadsworth M. Lifetime cognitive function and timing of the natural menopause. Neurology. 1999;53:308–14. [PubMed]
44. Cordell HJ, Clayton DG. Genetic association studies. Lancet. 2005;366:1121–31. [PubMed]
45. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I, et al. Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59:3229–39. [PMC free article] [PubMed]
46. Pankow JS, Boerwinkle E, Adams PC, Guallar E, Leiendecker-Foster C, Rogowski J, Eckfeldt JH. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res. 2008;152:3–10. [PMC free article] [PubMed]
47. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221. [PubMed]
48. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60. [PMC free article] [PubMed]
49. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008–12. [PubMed]
50. Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol. 2009;62:597–608.e4. [PubMed]
51. Benyamin B, McRae AF, Zhu G, Gordon S, Henders AK, Palotie A, Peltonen L, Martin NG, Montgomery GW, et al. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am J Hum Genet. 2009;84:60–5. [PubMed]
52. Schiepers OJG, van Boxtel MPJ, de Groot RHM, Jolles J, de Kort WLAM, Swinkels DW, Kok FJ, Verhoef P, Durga J. Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. J Gerontol A Biol Sci Med Sci. 2010;65:1312–21. [PubMed]
53. Wang FT, Hu H, Schwartz J, Weuve J, Spiro AS, Sparrow D, Nie H, Silverman EK, Weiss ST, Wright RO. Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Environ Health Perspect. 2007;115:1210–5. [PMC free article] [PubMed]
54. Taylor EM, Crowe A, Morgan EH. Transferrin and iron uptake by the brain: effects of altered iron status. J Neurochem. 1991;57:1584–92. [PubMed]
55. Collingwood J, Dobson J. Mapping and characterization of iron compounds in Alzheimer’s tissue. J Alzheimers Dis. 2006;10:215–22. [PubMed]
56. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB. Increased iron (III) and total iron content in post mortem substantia nigra of Parkinsonian brain. J Neural Transm. 1988;74:199–205. [PubMed]
57. Atamna H, Killilea DW, Killilea AN, Ames BN. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci USA. 2002;99:14807–12. [PubMed]
58. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr. 2000;71:614S–20S. [PubMed]
59. Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, de Jager C, Budge MM, Smith AD. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology. 2008;71:826–32. [PubMed]
60. Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 1995;9:526–33. [PubMed]
61. Berry DJ, Vimaleswaran KS, Whittaker JC, Hingorani AD, Hyppönen E. Evaluation of genetic markers as instruments for Mendelian randomization studies on vitamin D. PLoS ONE. 2012;7:e37465. [PMC free article] [PubMed]
62. van der Wielen RP, Löwik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346:207–10. [PubMed]
63. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–57. [PubMed]
64. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR., Jr Dietary supplements and mortality rate in older women: the Iowa Women’s Health Study. Arch Intern Med. 2011;171:1625–33. [PubMed]

Articles from The Journal of Nutrition are provided here courtesy of American Society for Nutrition